1. Home
  2. ELTK vs TENX Comparison

ELTK vs TENX Comparison

Compare ELTK & TENX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eltek Ltd.

ELTK

Eltek Ltd.

HOLD

Current Price

$8.54

Market Cap

61.6M

Sector

Technology

ML Signal

HOLD

Logo Tenax Therapeutics Inc.

TENX

Tenax Therapeutics Inc.

HOLD

Current Price

$13.61

Market Cap

56.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELTK
TENX
Founded
1970
1967
Country
Israel
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
61.6M
56.2M
IPO Year
1998
2001

Fundamental Metrics

Financial Performance
Metric
ELTK
TENX
Price
$8.54
$13.61
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$29.67
AVG Volume (30 Days)
3.2K
378.7K
Earning Date
03-09-2026
03-10-2026
Dividend Yield
2.23%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$16.18
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$48.71
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.65
$4.64
52 Week High
$12.19
$18.38

Technical Indicators

Market Signals
Indicator
ELTK
TENX
Relative Strength Index (RSI) 36.24 51.07
Support Level $8.38 $11.29
Resistance Level $9.19 $14.15
Average True Range (ATR) 0.18 1.26
MACD -0.06 0.02
Stochastic Oscillator 13.87 52.89

Price Performance

Historical Comparison
ELTK
TENX

About ELTK Eltek Ltd.

Eltek Ltd is engaged in the technology business sector that manufactures and supplies technologically new custom-made circuitry solutions. It manufactures, markets, and sells custom-made printed circuit boards (PCBs), including high-density interconnect, flex-rigid and multi-layered boards. The Company markets its products mainly to the medical technology, defense and aerospace, industrial, telecom, and networking equipment industries. Its geographic areas are Israel, North America, the Netherlands, India, and Others. It generates the majority of its revenue from Israel.

About TENX Tenax Therapeutics Inc.

Tenax Therapeutics Inc is a specialty pharmaceutical company focused on identifying, developing, and commercializing products that address cardiovascular and pulmonary diseases with high unmet medical needs. The company owns North American rights to develop and commercialize levosimendan and has released topline data regarding the Phase 2 clinical trial for the use of levosimendan in the treatment of pulmonary hypertension associated with Heart Failure and preserved Ejection Fraction.

Share on Social Networks: